Effectiveness of treatment of viral hepatitis with prednisolone and lysozyme
Bubliĭ, V.P.
Klinicheskaia Meditsina 56(6): 48-51
1978
ISSN/ISBN: 0023-2149 PMID: 672160 Document Number: 135807
Document emailed within 1 workday
Related Documents
Bubliĭ, V.P.; Vogdanova, V.I.; Zadorozhnaia, E.A.; Panchenko, L.A. 1973: Treatment of viral hepatitis with lysozyme Vrachebnoe Delo 9: 141-143Fiori, G.P.; Gandini, F.; Guazzotti, G. 1983: Effects of lysozyme treatment on immune reactions in viral hepatitis. Preliminary report Minerva Medica 74(25): 1457-1462
Titov, V.V. 1972: State of the water-electrolyte metabolism in viral hepatitis during prednisolone therapy Terapevticheskii Arkhiv 44(2): 48-53
Wysocki, H.; Burchardt, K.; Lawniczak, C.; Wierusz, B. 1974: Quantitative evaluation of the granulocyte system in viral hepatitis by way of determining plasma muramidase (lysozyme) activity Wiadomosci Lekarskie 27(9): 791-795
Nedoszytko, B.; Michalska, Z.; Dubicka, M.; Gajda, A. 1987: Evaluation of the effectiveness of isoprinosine in the treatment of patients with acute viral hepatitis. II. Immunological evaluation Wiadomosci Lekarskie 40(21): 1469-1474
Thornburg, L.P.; Sumerlin, S. 1981: Prednisolone as a treatment for chronic active hepatitis Veterinary Medicine-Small Animal Clinician 76(10): 1435-1436
Shudo, E.; Ribeiro, R.M.; Talal, A.H.; Perelson, A.S. 2008: A hepatitis C viral kinetic model that allows for time-varying drug effectiveness Antiviral Therapy 13(7): 919-926
Pár, A.; Paál, M.; Kádas, I.; Kerekes, E.; Jávor, T. 1983: Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study) Acta Medica Hungarica 40(1): 17-24
Su, S-Yung. 2019: The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan Hepatology International 13(2): 157-164
Pavelkina, V.F.; Ampleeva, N.P. 2014: Comparative effectiveness hepatotropic activity remaxol and Essentiale N in chronic viral hepatitis Eksperimental'naia i Klinicheskaia Farmakologiia 77(12): 17-21
Volzhanin, V.M.; Lobzin, I.V. 1984: Bicycle ergometry and psychophysiological studies in assessing the effectiveness of the rehabilitation of patients who have had viral hepatitis Voenno-Meditsinskii Zhurnal 7: 50-52
Pak, S.G.; Brodov, L.E.; Burnatseva, V.V.; Bogin, I.B. 1980: Clinical aspects of VZ viral hepatitis and the aggravating effect of herpes zoster on the course of infectious and serum viral hepatitis Klinicheskaia Meditsina 58(5): 47-49
Bocşan, I.S.; Gocan, G.; Ursu, L.; Brumboiu, M.I.; Soşa, I.; Simionca, L.; Sava, A.ţa.; Olaru, O.; Păştina, I. 2005: How protective is the immunization against viral hepatitis B prospectively? Seroprevalence study on viral hepatitis B infection Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 109(1): 124-130
Hobstová, J.; Vitous, A. 2011: Viral hepatitis at the beginning of the 21st century--value of liver biopsy in the context of development of new non-invasive diagnostic methods and in relation to the modern therapy of chronic viral hepatitis Ceskoslovenska Patologie 47(2): 44-49
Martynov, S.V.; Breeva, L.G.; Roenko, N.F. 1977: Dynamic changes of lysozyme concentration in the blood serum in patients with typhoid fever treated levomycetin in conjunction with prednisolone and butadione Sovetskaia Meditsina 6: 127-128
Xu, J.-h.; Yu, Y.-y.; Si, C.-w.; Chen, X.-y.; Han, Z.-h.; Chen, Y.; Li, X.-y. 2009: A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment Zhonghua Yi Xue Za Zhi 89(41): 2902-2905
Aleĭnik, M.D. 1970: Epidemiologic patterns in the spread of viral hepatitis. I. Dynamics of viral hepatitis morbidity Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 47(1): 63-66
Nolte, I.; Niemann, C.; Failing, K.; Müller-Berghaus, G. 1988: The effectiveness of the combined treatment of thrombocytic hemorrhagic diathesis of dogs with prednisolone and blood transfusion in the model of an aspirin-produced thrombocytopathy Tierarztliche Praxis 16(4): 417-422
Maki, K. 1979: Viral hepatitis and HB antigen. Viral hepatitis and occupation-related diseases Nursing Technique 25(3): 96-111
Hudecková, H.; Straka, S.; Szilágyiová, M.; Avdicová, M.; Rusnáková, S. 2002: Cost effectiveness and cost benefit of viral hepatitis B vaccination in the Slovak Republic Central European Journal of Public Health 10(4): 146-148